September 22 - 25, 2022


This activity has been approved for 21.75 AMA PRA Category 1 Credit(s)™

2022 Presentations (Available through Oct 31)
The credit claiming and evaluation period for the 2022 event has ended. Information about next year's event (September 7-10, 2023) will be posted here in the spring of 2023.

About the Symposium

The 24th Annual Lynn Sage Breast Cancer Symposium
will be held in person in Chicago!

Referred to as the most valuable breast cancer meeting worldwide for the practicing clinician, the Lynn Sage Breast Cancer Symposium will provide 3.5 days of presentations and interactive Q&A sessions in downtown Chicago this September.

For over 20 years, this multidisciplinary CME program has provided the latest information regarding cutting-edge technology and approaches in the management of breast cancer from leading national and international medical, surgical, and radiation oncologists.This year's symposium will include a superb line-up of internationally recognized faculty who will not only present the latest research findings, but will also be available for real-time interaction following their presentations. The symposium will focus on the close cooperation required for effective multidisciplinary management of patients with breast cancer.

This in-person symposium will offer:

  • 3.5 days of in-person presentations and Q&A with over 30 international breast cancer experts
  • Exhibit hall with pharmaceutical companies
  • Online access to presentation slides in PDF format (through October 31)
  • Continuing education credits & MOC available
  • Catered breakfast, break refreshments, and a reception. Lunch available for purchase Thursday through Saturday.

*Please note this year's symposium will take place fully in person in Chicago.

William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center
Northwestern University

Monica Morrow, MD
Memorial Sloan Kettering Cancer Center
Scientific Planning Committee Members

Nora Hansen, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Kalliopi Siziopikou, MD, PhD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Jonathan Strauss, MD, MBA
Robert H. Lurie Comprehensive Cancer Center of Northwestern University


  • Future Issues in Breast Cancer
  • Breast Pathology for the Non-Pathologist
  • Breast Imaging and Risk Management
  • TNBC and Advanced Dx
  • Management of ER+ Disease
  • Controversies in HER2+ breast cancer
  • Unresolved Clinical Problems
Full Agenda »


Get information about registration and the latest news by subscribing to our email list.


Please join the conversation on Twitter before, during and after the conference by connecting with us @LurieCancer, and using the hashtag #LSBC22

© 2022 Robert H. Lurie Comprehensive Cancer Center